Product logins

Find logins to all Clarivate products below.


Spinal Implants | Market Insights | Asia Pacific | 2021

While the COVID-19 pandemic will significantly impact the market in the short term, other factors, such as favorable demographics and increased access to health care in some of the countries covered, will ultimately lead to growth in the Asia Pacific spinal implant market through 2029. Although the spinal implant market will be somewhat limited by pricing pressures, challenging reimbursement environments, and nationalist policies in China and India, advancements in medical facilities and an increased focus on physician training will lead to overall spinal implant market growth.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for spinal implants in the Asia Pacific region across a 10-year period.

Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…
Report
Structural Heart Closure Devices – Market Insights – Asia Pacific
The Asia Pacific structural heart closure device market will grow strongly overall through 2034, supported by rising AF prevalence, increasing physician confidence in structural heart interventions…
Report
Trauma Devices – Market Insights – Europe
Although financial constraints among European healthcare facilities and the rise of GPOs that will exert downward pressure on ASPs will limit the European trauma device market, favorable…
Report
Trauma Devices – Market Insights – Latin America
The Latin American trauma device market is positioned for strong growth, driven by the rapid expansion of highvolume product segments, a growing aging population, and increasingly favorable…
Report
Diabetes Care Devices – Market Insights – Asia Pacific
The Asia Pacific diabetes care device market is expected to experience moderate growth over the forecast period, driven by a rising diabetes population, untapped market opportunities, regulatory…